Nalaganje...

BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy

BRAF and MEK inhibitors (BRAFi/MEKi), the standard treatment for patients with BRAFV600 mutated melanoma, are currently explored in combination with various immunotherapies, notably checkpoint inhibitors and adoptive transfer of receptor-transfected T cells. Since two BRAFi/MEKi combinations with si...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F. Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2018-01-01
Serija:International Journal of Molecular Sciences
Teme:
Online dostop:http://www.mdpi.com/1422-0067/19/1/289
Oznake: Označite
Brez oznak, prvi označite!